Control of Germinal Center Localization and Lineage Stability of Follicular Regulatory T Cells by the Blimp1 Transcription Factor.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
12 11 2019
Historique:
received: 10 11 2017
revised: 19 07 2019
accepted: 02 10 2019
entrez: 14 11 2019
pubmed: 14 11 2019
medline: 17 9 2020
Statut: ppublish

Résumé

Follicular regulatory T (T

Identifiants

pubmed: 31722202
pii: S2211-1247(19)31312-9
doi: 10.1016/j.celrep.2019.10.012
pmc: PMC6897316
mid: NIHMS1542975
pii:
doi:

Substances chimiques

CXCR5 protein, mouse 0
Ccr7 protein, mouse 0
Il2ra protein, mouse 0
Interleukin-2 Receptor alpha Subunit 0
Prdm1 protein, mouse 0
Receptors, CCR7 0
Receptors, CXCR5 0
Receptors, Interleukin 0
STAT3 Transcription Factor 0
STAT5 Transcription Factor 0
Stat3 protein, mouse 0
interleukin-23 receptor, mouse 0
Positive Regulatory Domain I-Binding Factor 1 EC 2.1.1.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1848-1861.e6

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI037562
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI048125
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Erxia Shen (E)

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA; Department of Pathogenic Biology and Immunology, Guangzhou Hoffmann Institute of Immunology, School of Basic Sciences, Guangzhou Medical University, Guangzhou 510182, China.

Hardis Rabe (H)

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.

Lin Luo (L)

Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL 35233, USA; School of Pharmacy and Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Nantong University, Nantong, Jiangsu 226001, China.

Lei Wang (L)

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.

Qin Wang (Q)

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA; Department of Immunology, Medical College of Soochow University, Suzhou, Jiangsu 215123, China.

Jie Yin (J)

Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL 35233, USA; Department of Cell Biology, Tianjin Medical University, Tianjin 300070, China.

Xueying Yang (X)

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.

Wenquan Liu (W)

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA; Department of Parasitology, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.

Jessica M Sido (JM)

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.

Hidetoshi Nakagawa (H)

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.

Lin Ao (L)

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.

Hye-Jung Kim (HJ)

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.

Harvey Cantor (H)

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: harvey_cantor@dfci.harvard.edu.

Jianmei W Leavenworth (JW)

Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL 35233, USA; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35233, USA. Electronic address: jleavenworth@uabmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH